Financing round led by new investor Viking Global Investors with participation from key existing investorsContinue reading→

— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures —

— Advancing second-generation Emperor TAH development toward a fully implantable system —
Continue reading→

These programs provide non-dilutive funding to help small businesses advance innovative technologies and bring promising discoveries closer to commercialization. Whether you’re developing a new therapeutic, diagnostic, medical device, digital health solution, or research tool, NIH funding can help accelerate your path forward.Continue reading→

Milestones in Research details 1,300 clinical and translational research studies, FDA-approved heart device, landmark Alzheimer’s prevention work

Continue reading→

Memorial Day is a time to remember and honor the men and women who gave their lives in military service to our country. Some died in war time, others died in peacetime. Some died in foreign lands, others died right here at home. We also remember service members who through their injuries, exposure to toxins, or wartime experiences had lives that ended too soon even though they made it home alive. Their sacrifice is the highest price that can be paid for the opportunities we have as Americans. Today, we remember them, honor them, and most if all, should be thankful for the lives that they lived and the sacrifice that they made for us.Continue reading→

Chronic HDV is considered the most severe form of viral hepatitis due to rapid disease progression towards liver failure and liver-related death –

– Approval introduces the first FDA-approved therapy for this disease with limited treatment options and high unmet need
Continue reading→

For the second straight year, the University of Arizona College of Medicine – Phoenix hosted Research Week. The series of events, bridged between two weeks, served as a fantastic showcase for how the college and its partners are driving discovery and fueling the future of healthier Arizona.Continue reading→

Christopher K. Finch, Pharm.D., FCCM, FCCP has been appointed dean of the R. Ken Coit College of Pharmacy, effective Aug. 1, following a collaborative and comprehensive national search that involved the broader campus community.Continue reading→

His lab will focus on advancing immuno‑oncology and microbiome innovation and research on understanding and interrupting tumor–immune interactionsContinue reading→

Dr. Nageatte Ibrahim helped guide the clinical development of Keytruda, one of the most consequential immuno-oncology therapiesContinue reading→